These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27988018)

  • 1. Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery.
    Alavi S; Haeri A; Dadashzadeh S
    Carbohydr Polym; 2017 Feb; 157():991-1012. PubMed ID: 27988018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
    Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
    Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based drug delivery systems.
    Bernkop-Schnürch A; Dünnhaupt S
    Eur J Pharm Biopharm; 2012 Aug; 81(3):463-9. PubMed ID: 22561955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery.
    Islam N; Ferro V
    Nanoscale; 2016 Aug; 8(30):14341-58. PubMed ID: 27439116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
    Huang A; Makhlof A; Ping Q; Tozuka Y; Takeuchi H
    Drug Deliv; 2011 Nov; 18(8):562-9. PubMed ID: 21823926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-Based Nanomaterials for Drug Delivery.
    Li J; Cai C; Li J; Li J; Li J; Sun T; Wang L; Wu H; Yu G
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30332830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities offered by chitosan-based nanotechnology in mucosal/skin drug delivery.
    Sandri G; Bonferoni MC; Ferrari F; Rossi S; Mori M; Caramella C
    Curr Top Med Chem; 2015; 15(4):401-12. PubMed ID: 25579349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.
    Ahmed TA; Aljaeid BM
    Drug Des Devel Ther; 2016; 10():483-507. PubMed ID: 26869768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
    Qu G; Wu X; Yin L; Zhang C
    Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
    Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic parameters for the synthesis and tuned properties of amphiphilic chitosan drug delivery nanocarriers.
    Motiei M; Kashanian S; Lucia LA; Khazaei M
    J Control Release; 2017 Aug; 260():213-225. PubMed ID: 28625671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
    Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
    Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
    Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
    Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review.
    Lang X; Wang T; Sun M; Chen X; Liu Y
    Int J Biol Macromol; 2020 Jul; 154():433-445. PubMed ID: 32194103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications.
    Bugnicourt L; Ladavière C
    J Control Release; 2017 Jun; 256():121-140. PubMed ID: 28414148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-coated liposomes for delivery to lungs by nebulisation.
    Zaru M; Manca ML; Fadda AM; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan: a unique polysaccharide for drug delivery.
    Felt O; Buri P; Gurny R
    Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan/lecithin liposomal nanovesicles as an oral insulin delivery system.
    Al-Remawi M; Elsayed A; Maghrabi I; Hamaidi M; Jaber N
    Pharm Dev Technol; 2017 May; 22(3):390-398. PubMed ID: 27470482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive graphene-incorporated multifunctional chitosan for drug delivery applications: a review.
    Gooneh-Farahani S; Naimi-Jamal MR; Naghib SM
    Expert Opin Drug Deliv; 2019 Jan; 16(1):79-99. PubMed ID: 30514124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.